Key Record Dates
ClinicalTrials.gov Identifier: | NCT03038100 |
---|---|
Brief Title: | A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (IMagyn050) |
First Submitted : | January 30, 2017 |
First Submitted that Met QC Criteria : | January 30, 2017 |
First Posted : | January 31, 2017 (Estimate) |
Last Update Submitted that Met QC Criteria : | November 7, 2022 |
Last Update Posted : | November 9, 2022 |